THC - CIK 0000070318
The table below shows TENET HEALTHCARE CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.64B | $815.00M | $586.00M | - | - | $449.00M |
| Capital expenditure | $180.00M | $173.00M | $240.00M | $176.00M | $132.00M | $235.00M |
| Investing cash flow | -$317.00M | -$187.00M | $3.33B | - | - | -$286.00M |
| Dividends paid | - | - | - | - | - |
TENET HEALTHCARE CORP reported operating cash flow of $3.54B for fiscal year 2025. That is up 72.9% from $2.05B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $558.00M (FY 2016) to $3.54B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $318.00M | $348.00M | $278.00M | - | - | $50.00M |
| Financing cash flow | -$1.24B | -$648.00M | -$2.66B | - | - | -$255.00M |